Evidence map›Paper›PMID 40948607›Full record

ArticleIn silico pharmacology2025

Therapeutic potential of

Rashmi Sahu, Rajan Mariappan, Awanish Kumar, Arun Kumar Mahapatra, S Rajagopala, Prashant Kumar Gupta

Abstract read
In one paragraph

Article in In silico pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rashmi SahuDepartment of Kaumarabhritya, Ayurinformatics Laboratory, All India Institute of Ayurveda, New Delhi, India.
Rajan MariappanDepartment of Natural Product Chemistry, Madurai Kamaraj University, Madurai, Tamil Nadu India.
Awanish KumarDepartment of Biotechnology, National Institute of Technology, Raipur, Chhattisgarh India.
Arun Kumar MahapatraDepartment of Kaumarabhritya, Ayurinformatics Laboratory, All India Institute of Ayurveda, New Delhi, India.
S RajagopalaDepartment of Kaumarabhritya, Ayurinformatics Laboratory, All India Institute of Ayurveda, New Delhi, India.
Prashant Kumar GuptaDepartment of Kaumarabhritya, Ayurinformatics Laboratory, All India Institute of Ayurveda, New Delhi, India.ORCID 0000-0002-2368-1852

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monkeypox, a viral zoonotic disease caused by the monkeypox virus (MPXV), has recently become a significant global health threat due to increased human-to-human transmission. As of November 2023, the Mpox outbreak had impacted 116 countries worldwide, with a total of 92,783 confirmed cases and 171 reported deaths. With limited antiviral options available, natural plant-based compounds like Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-025-00423-4.

Indexed as

Andrographis panniculataAyurinformaticsAyurvedaMonkey pox

Identifiers

PMID40948607
PMCPMC12423014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.